or
forgot password
  • cancer clinical trials in houston, TX

  • Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Mesothelioma
    Erlotinib Prevention of Oral Cancer (EPOC)
    The Univeristy of Texas M. D. Anderson Cancer Center
    Houston, Texas 77030
    Oral Cancer
    Malignant Pleural Effusion With ZD6474
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lung Cancer, Pleural Effusion
    Study of ATN-224 in Patients With Prostate Cancer
    University of Texas MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Safety Study of PLX4032 in Patients With Solid Tumors
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Malignant Melanoma, Colorectal Carcinoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Baylor College of Medicine
    Houston, Texas 77030
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    BATTLE Program: Umbrella Protocol for Patients With NSCLC
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lung Cancer
    BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lung Cancer
    Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Lymphoma
    BATTLE Program: Tarceva and Targretin in Patients With NSCLC
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lung Cancer
    Smoking Status and Body Image in Oral Cancer Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Oral Cavity Cancer
    2CDA With Rituximab in Hairy Cell Leukemia
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia
    All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Acute Promyelocytic Leukemia
    5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Chronic Lymphocytic Leukemia, Leukemia
    Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leiomyosarcoma, Uterine Neoplasm
    Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Myelodysplastic Syndrome, Acute Myelogenous Leukemia
    Gliogene: Brain Tumor Linkage Study
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    UT MD Anderson Cancer Center
    Texas Children's Hospital
    Brain Tumor, Glioma
    Parenteral Hydration in Advanced Cancer Patients
    UT MD Anderson Cancer Center

    Trial Locations
    UT MD Anderson Cancer Center
    Odyssey Healthcare of Houston
    Houston Hospice and Palliative Care System
    Vitas Healthcare
    Advanced Cancer, Dehydration
    Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Mucosal Melanoma, Acral/Lentiginous Melanoma, Chronically Sun Damaged Melanomas
    PS-341 Followed by Removal of Prostate for Those With Prostate Cancer
    Scott Department of Urology, Baylor College of Medicine
    Houston, Texas 77030
    Prostate Neoplasms
    Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
    MD Anderson Cancer Center/University of Texas StudyCoordinator:CLBH589B2201
    Houston, Texas 77030
    Cutaneous T-Cell Lymphoma
    A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
    U.T. M.D. Anderson Cancer Center
    Houston, Texas 77030
    Peripheral T-cell Lymphoma
    A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
    Pfizer Investigational Site
    Houston, Texas 77030
    Metastatic Breast Cancer, Advanced Breast Cancer, Advanced Gastric Cancer, Advanced/Metastatic Non-small Cell Lung Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Metastatic Castration-resistant Prostate Cancer, Metastatic Renal Cell Cancer, Non Small Cell Lung Cancer, Pancreatic Islet Cell Carcinoma, Pancreatic Neuroendocrine Tumor, Thyroid Cancer
    3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer, Bone Metastases
    Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Retinoblastoma
    Optical Imaging of Skin Cancers for Margin Delineation of Non-melanoma Skin Cancers
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Skin Cancer
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    M D Anderson Cancer Center
    Houston, Texas 77030
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Baylor College of Medicine
    Houston, Texas 77030
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    MD Anderson Cancer Center/University of Texas Dept.ofMDAndersonCancerCtr(8)
    Cushing's Disease
    Oral Margin Spectroscopy Detection Using Optical Spectroscopy
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Oral Tumors
    Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
    MD Anderson Cancer Center - Dept. of Lymphoma and Myeloma
    Houston, Texas 77030-4009
    Hodgkin's Lymphoma
    Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
    St. Lukes Episcopal Hospital

    Trial Locations
    St. Lukes Episcopal Hospital
    Excel Diagnostic Imaging Clinics
    Neuroendocrine Tumors
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    M. D. Anderson Cancer Center at University of Texas

    Trial Locations
    M. D. Anderson Cancer Center at University of Texas
    Methodist Hospital
    Bladder Cancer
    Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lung Cancer
    Pegasys® in Patients With Myeloproliferative Diseases
    U.T.M.D. Anderson Cancer Center
    Houston, Texas 77030
    Myeloproliferative Disorders
    A Study of Actonel for the Prevention of Bone Loss
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia, Lymphoma
    Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer, Cervical Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer
    Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Gastrinoma, Glucagonoma, Insulinoma, Metastatic Gastrointestinal Carcinoid Tumor, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2, Pancreatic Polypeptide Tumor, Pulmonary Carcinoid Tumor, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Regional Gastrointestinal Carcinoid Tumor, Somatostatinoma, WDHA Syndrome
    Evaluating Materials to Educate Patients About Cervical Dysplasia
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Education, Cervical Dysplasia
    Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
    Celldex Investigational Site
    Houston, Texas 77030
    Malignant Glioma
    Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
    The Methodist Hospital
    Houston, Texas 77030
    Chronic Lymphocytic Leukemia (CLL)
    Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
    M D Anderson Cancer Center
    Houston, Texas 77030
    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Progressive Hairy Cell Leukemia, Initial Treatment, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IVA Mycosis Fungoides/Sezary Syndrome, Stage IVB Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Recurrent Endometrial Carcinoma
    Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML
    The University of Texas MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Chronic Myeloid Leukemia
    A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
    MD Anderson Cancer Center Leukemia Department
    Houston, Texas 77030
    Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis
    Trial of Dasatinib in Advanced Sarcomas
    MD Anderson
    Houston, Texas 77230
    Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors, Chondrosarcoma, Sarcoma, Ewing's, Sarcoma, Alveolar Soft Part, Chordoma, Epithelioid Sarcoma, Giant Cell Tumor of Bone, Hemangiopericytoma, Gastrointestinal Stromal Tumor (GIST)
    3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Renal Cell Cancer, Kidney Cancer
    Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Lymphoma
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Baylor University Medical Center - Houston
    Houston, Texas 77030-2399
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Mentor Integration Study
    M.D. Anderson
    Houston, Texas 77030
    CHESS and Cancer Mentor, CHESS Only, Mentor Only, Control (Internet Only)